Pharma channel feed – Endpoints News

Pharma channel feed

At #JPM23, another rare disease buyout as Ipsen acquires Albireo for $952M

3 years ago

Novartis offloads neurodevelopmental disorder asset to small Swiss biotech

3 years ago

#JPM23 kicks off with an acquisition as Chiesi inks all-cash $1B+ deal for Amryt

3 years ago

Emergent awarded $379M+ to supply the DOD with a skin decontamination lotion

3 years ago

Eisai prices Alzheimer's drug at $26,500, below partner Biogen's Aduhelm

3 years ago

BioNTech inks partnership with UK to speed up recruitment of mRNA cancer trials

3 years ago

FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate

3 years ago

Breaking: FDA clears second Alzheimer's drug in 'foundational spark' for field

3 years ago

Brands in demand: Keytruda, Dupixent and Ozempic lead 2023 new sales predictions — Evaluate report

3 years ago

Fate and J&J end deal that once promised $3B in milestones; biotech cuts staff

3 years ago

Intellia plots pivotal trials for lead programs as it lays out key objectives

3 years ago

Bausch + Lomb tackles glaucoma awareness and research funding with nonprofit partner in new campaign

3 years ago

Ready for takeoff: J&J's consumer health unit Kenvue files for official separation

3 years ago

Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal

3 years ago

Klick Group hires McKinsey life science commercialization chief to amp offerings

3 years ago

Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year

3 years ago

Pfizer leads top-selling pharma forecast — Evaluate report

3 years ago

Metabolic disease outfit accuses Chinese biotech of stealing trade secrets to advance competing drug

3 years ago

January’s new drug price increases take off without overcompensating for upcoming inflation-linked rebates

3 years ago

Federal court deals blow to Gilead and Astellas in patent case against Pfizer generic

3 years ago

FDA policy change opens the door for abortion pill in pharmacies

3 years ago

Capsida makes $55M deal with Eli Lilly to develop gene therapies

3 years ago

Athenex to exit drug compounding business and axe 92 employees at NY plant

3 years ago

CMS needs to strengthen its internal controls to ensure Part B drug payment accuracy, OIG finds

3 years ago

First page Previous page 153 154 155156157 158 159 Next page Last page